EUVIMEDEUVIMED entdecken
Open Access

MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity

Shan Zhou, Xian Ling, Jielin Zhu, Ye Liang, Qijian Feng, Chao Xie, Jiemei Li, Qiyan Chen, Shuangqin Chen, Jinhua Miao, Mengyao Zhang, Zhiru Li und 10 weitere

Theranostics · 2024 · 14 (4) · 1583-1601

DOI: 10.7150/thno.92848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Shan Zhou und 21 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangdong Provincial Clinical Research Center fo…. Hauptthemen laut MEDLINE: Monoacylglycerol Lipases, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 34-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Renal fibrosis, with no therapeutic approaches, is a common pathological feature in various chronic kidney diseases (CKD). Tubular cell injury plays a pivotal role in renal fibrosis. Commonly, injured tubular cells exhibit significant lipid accumulation. However, the underlying mechanisms remain poorly understood.

Methods

2-arachidonoylglycerol (2-AG) levels in CKD patients and CKD model specimens were measured using mass spectrometry. 2-AG-loaded nanoparticles were infused into unilateral ureteral obstruction (UUO) mice. Lipid accumulation and renal fibrosis were tested. Furthermore, monoacylglycerol lipase (MAGL), the hydrolyzing enzyme of 2-AG, was assessed in CKD patients and models. Tubular cell-specific MAGL knock-in mice were generated. Moreover, MAGL recombination protein was also administered to unilateral ischemia reperfusion injury (UIRI) mice. Besides, a series of methods including RNA sequencing, metabolomics, primary cell culture, lipid staining, etc. were used.

Results

2-AG was increased in the serum or kidneys from CKD patients and models. Supplement of 2-AG further induced lipid accumulation and fibrogenesis through cannabinoid receptor type 2 (CB2)/β-catenin signaling. β-catenin knockout blocked 2-AG/CB2-induced fatty acid β-oxidation (FAO) deficiency and lipid accumulation. Remarkably, MAGL significantly decreased in CKD, aligning with lipid accumulation and fibrosis. Specific transgene of MAGL in tubular cells significantly preserved FAO, inhibited lipid-mediated toxicity in tubular cells, and finally retarded fibrogenesis. Additionally, supplementation of MAGL in UIRI mice also preserved FAO function, inhibited lipid accumulation, and protected against renal fibrosis.

Conclusion

MAGL is a potential diagnostic marker for kidney function decline, and also serves as a new therapeutic target for renal fibrosis through ameliorating lipotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monoacylglycerol LipasesRenal Insufficiency, ChronicAnimalsHumansMicebeta CateninFibrosisKidney

Stichwörter der Autor:innen

2-AGFAOMAGLlipotoxicityrenal fibrosis

Substanzen

beta CateninMonoacylglycerol LipasesMGLL protein, humanMgll protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangdong Provincial Clinical Research Center for Kidney Disease, Guangdong Provincial Key Laboratory of Nephrology, D…
  • Department of Health Care, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Nephrology Department, The First People's Hospital of Foshan, Foshan, China.
  • Division of Nephrology, Department of medicine, The Fifth Affiliated Hospital Sun Yat-Sen University, Zhuhai, China.
  • School of Pharmaceutical Sciences and School of Biomedical Engineering, Southern Medical University, Guangzhou, China.

Zitieren

APA

Zhou, S., Ling, X., Zhu, J., Liang, Y., Feng, Q., Xie, C., Li, J., Chen, Q., Chen, S., Miao, J., Zhang, M., Li, Z., Shen, W., Li, X., Wu, Q., Wang, X., Liu, R., Wang, C., Hou, F. F., …, & Zhou, L. (2024). MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity. Theranostics, 14(4), 1583-1601. https://doi.org/10.7150/thno.92848

Vancouver

Zhou S, Ling X, Zhu J, Liang Y, Feng Q, Xie C, et al. MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity. Theranostics. 2024;14(4):1583-1601. doi:10.7150/thno.92848

BibTeX
@article{Zhou2024,
  author = {Zhou, Shan and Ling, Xian and Zhu, Jielin and Liang, Ye and Feng, Qijian and Xie, Chao and Li, Jiemei and Chen, Qiyan and Chen, Shuangqin and Miao, Jinhua and Zhang, Mengyao and Li, Zhiru and Shen, Weiwei and Li, Xiaolong and Wu, Qinyu and Wang, Xiaoxu and Liu, Ruiyuan and Wang, Cheng and Hou, Fan Fan and Kong, Yaozhong and Liu, Youhua and Zhou, Lili},
  title = {MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {1583--1601},
  doi = {10.7150/thno.92848}
}
Kostenlos starten →